| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |